Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine Volume for IPACK Block in TKA
NCT05438992Completed
- Sponsor
- Cairo University
- Start
- Dec 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (3 arms), sponsored by Cairo University. Primary endpoint: Visual Analogue Scale for Pain at 24 hours. Started Dec 2023; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05438992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05438992.